Back to Journals » Infection and Drug Resistance » Volume 7

Infection and Drug Resistance

ISSN: 1178-6973


Archive: Volume 7, 2014

Antibiotic lock therapy: review of technique and logistical challenges

Justo JA, Bookstaver PB

Infection and Drug Resistance 2014, 7:343-363

Published Date: 12 December 2014

Current perspectives on the spread of dengue in India

Gupta E, Ballani N

Infection and Drug Resistance 2014, 7:337-342

Published Date: 11 December 2014

Does antimicrobial use density at the ward level influence monthly central line-associated bloodstream infection rates?

Yoshida J, Harada Y, Kikuchi T, Asano I, Ueno T, Matsubara N

Infection and Drug Resistance 2014, 7:331-335

Published Date: 1 December 2014

The effect of a unique propolis compound (PropoelixTM) on clinical outcomes in patients with dengue hemorrhagic fever

Soroy L, Bagus S, Yongkie IP, Djoko W

Infection and Drug Resistance 2014, 7:323-329

Published Date: 9 December 2014

Virulence and antimicrobial resistance of Escherichia coli isolated from Tigris River and children diarrhea

Ibrahim IA, Al-Shwaikh RM, Ismaeil MI

Infection and Drug Resistance 2014, 7:317-322

Published Date: 26 November 2014

Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients

AbdulWahab A, Taj-Aldeen SJ, Ibrahim E, Abdulla SH, Muhammed R, Ahmed I, Abdeen Y, Sadek O, Abu-Madi M

Infection and Drug Resistance 2014, 7:309-316

Published Date: 20 November 2014

Bacterial bloodstream infections and antimicrobial susceptibility pattern in pediatric hematology/oncology patients after anticancer chemotherapy

Al-Mulla NA, Taj-Aldeen SJ, El Shafie S, Janahi M, Al-Nasser AA, Chandra P

Infection and Drug Resistance 2014, 7:289-299

Published Date: 6 November 2014

An economic model to compare linezolid and vancomycin for the treatment of confirmed methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany

Patel DA, Michel A, Stephens J, Weber B, Petrik C, Charbonneau C

Infection and Drug Resistance 2014, 7:273-280

Published Date: 24 October 2014

Optimizing antimicrobial therapy in critically ill patients

Vitrat V, Hautefeuille S, Janssen C, Bougon D, Sirodot M, Pagani L

Infection and Drug Resistance 2014, 7:261-271

Published Date: 20 October 2014

Genotypes and phenotypes of Shiga toxin-producing Escherichia coli (STEC) in Abeokuta, Southwestern Nigeria

Olowe OA, Aboderin BW, Idris OO, Mabayoje VO, Opaleye OO, Adekunle OC, Olowe RA, Akinduti PA, Ojurongbe O

Infection and Drug Resistance 2014, 7:253-259

Published Date: 15 October 2014

Host–pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicity

Steiner DJ, Furuya Y, Metzger DW

Infection and Drug Resistance 2014, 7:239-251

Published Date: 18 September 2014

Moxifloxacin resistance in the F15/LAM4/KZN extensively drug-resistant strain of Mycobacterium tuberculosis

Dookie N, Sturm AW, Moodley P

Infection and Drug Resistance 2014, 7:223-228

Published Date: 19 August 2014

Actinomycosis: etiology, clinical features, diagnosis, treatment, and management

Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, Gleizal A, Boussel L, Laurent F, Braun E, Chidiac C, Ader F, Ferry T

Infection and Drug Resistance 2014, 7:183-197

Published Date: 5 July 2014

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia

Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Mehmood M

Infection and Drug Resistance 2014, 7:177-182

Published Date: 27 June 2014

Corticosteroids in the treatment of dengue shock syndrome

Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC

Infection and Drug Resistance 2014, 7:137-143

Published Date: 22 May 2014

Gold mining areas in Suriname: reservoirs of malaria resistance?

Adhin MR, Labadie-Bracho M, Vreden S

Infection and Drug Resistance 2014, 7:111-116

Published Date: 5 May 2014

Long-term efficacy and safety of raltegravir in the management of HIV infection

Liedtke MD, Tomlin CR, Lockhart SM, Miller MM, Rathbun RC

Infection and Drug Resistance 2014, 7:73-84

Published Date: 18 March 2014

Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection

Leistner R, Sakellariou C, Gürntke S, Kola A, Steinmetz I, Kohler C, Pfeifer Y, Eller C, Gastmeier P, Schwab F

Infection and Drug Resistance 2014, 7:57-62

Published Date: 13 March 2014

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Kohler JJ, Nettles JH, Amblard F, Hurwitz SJ, Bassit L, Stanton RA, Ehteshami M, Schinazi RF

Infection and Drug Resistance 2014, 7:41-56

Published Date: 5 March 2014

Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections

Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL

Infection and Drug Resistance 2014, 7:25-35

Published Date: 18 February 2014

Update on otitis media – prevention and treatment

Qureishi A, Lee Y, Belfield K, Birchall JP, Daniel M

Infection and Drug Resistance 2014, 7:15-24

Published Date: 10 January 2014

Limiting and controlling carbapenem-resistant Klebsiella pneumoniae

Saidel-Odes L, Borer A

Infection and Drug Resistance 2014, 7:9-14

Published Date: 10 December 2013